1. Targeted Drug Delivery SystemLIPOSOMES 2. Learning Objectives• Introduction• Mechanism of liposome formation• Classification of liposomes• Material used in preparation…

Slide 1Billing 3 rd Party Payors for Services as part of Clinical Research Presented by OCRA to the Research Committee March 3, 2010 Slide 2 Background of CMS Clinical Trials…

Andy Pope Platform Technology & Science, GlaxoSmithKline, Collegeville PA, USA MipTec 2011, Basel Sept. 20-22, 2011 The Interplay between Chemical Properties and Screening…

3D microtissue models for oncology research Jointly developed by SIRION BIOTECH GmbH and InSphero AG By Dr. Christian Thirion, CEO and Co-Founder of SIRION BIOTECH GmbH It…

i PROPOXYPHENE, NORPROPOXYPHENE, AND PROADIFEN (SKF-525A) ARE MECHANISM-BASED INHIBITORS OF CYP3A4, CYP3A5, AND CYP3A IN HUMAN LIVER MICROSOMES Anna Ruth Riley Submitted…

Slide 1Company Presentation November 2010 Dr Julian Gilbert Slide 2 Introduction Acacia Pharma is a focused, cancer supportive care company –A significant, growing commercial…

Slide 1 Investigator-Initiated Research: Opportunities and Obstacles Michael R. Hamrell, Ph.D. MORIAH Consultants February 2007 Slide 2 Investigator-Initiated Originated…

Slide 1 THE UNIVERSITY OF NEW MEXICO ▪ HEALTH SCIENCES CENTER Clinical and Translational Science Center (CTSC) http://hsc.unm.edu/research/ctsc/ 4/2009 Slide 2  An exemption…

Choose the disease to cure: Diabetes Lung cancer Arthritis Alzheimerâs disease Coronary artery disease (heart disease) Obesity Asthma Drug Development Summary Sheet Drug…